US Pre-Market SEC Filings Roundup — September 10, 2026
Overnight filings reveal a market bifurcated between aggressive capital deployment and insider profit-taking. Axogen's $200M acquisition of BioCircuit Technologies and Indaptus' $24M raise signal continued M&A and financing activity in medtech, while Elevance Health's reaffirmed guidance provides stability in managed care. Insider activity is notably heavy in bitcoin miners (CleanSpark, TeraWulf) and Dell Technologies, where Silver Lake entities are systematically reducing stakes at ~$515-519/share, suggesting potential valuation concerns at current levels. Biohaven's partial clinical hold introduces regulatory overhang in neurology, partially offset by a new licensing deal with SK Biopharmaceuticals. The Equitable-Corebridge merger advances with quantified synergies, while YPF's debt tender offer and H World's $470M bond pricing reflect active liability management. SPAC activity (Elevation Acquisition IPO, XCF Global meeting postponement) and a 22.7% activist stake in Abits Group highlight continued special situations. Overall, the tape is constructive but selective, with capital flowing to growth and consolidation while insiders in high-flying sectors take profits.